(Q40641001)

22 September 2017

title

BR96 conjugates of highly potent anthracyclines (English)

1 reference

22 September 2017

H Dalton King

1

1 reference

22 September 2017

Andrew J Staab

2

1 reference

22 September 2017

Kahnie Pham-Kaplita

3

1 reference

22 September 2017

Derek Yurgaitis

4

1 reference

22 September 2017

Raymond A Firestone

5

1 reference

22 September 2017

Shirley J Lasch

6

1 reference

22 September 2017

Pamela A Trail

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

22 September 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

22 September 2017

volume

13

1 reference

22 September 2017

issue

13

1 reference

22 September 2017

page(s)

2119-2122

1 reference

New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

Anti-tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

N-(5,5-diacetoxypent-1-yl)doxorubicin: a new intensely potent doxorubicin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

Intensely potent morpholinyl anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

Antibody conjugates with morpholinodoxorubicin and acid cleavable linkers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900375-5

7 January 2021

10.1016/S0960-894X(03)00375-5

Identifiers

DOI

1 reference

22 September 2017

1 reference